Author

Tessa E.H. Römkens

LOSS OF RESPONSE AND DOSE ESCALATION OF INFLIXIMAB AND ADALIMUMAB IN ULCERATIVE COLITIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
LOSS OF RESPONSE AND DOSE ESCALATION OF INFLIXIMAB AND ADALIMUMAB IN ULCERATIVE COLITIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Tessa E.H. Römkens  et al.

WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDY
WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDY

Tessa E.H. Römkens  et al.

REAL-WORLD IMPACT OF BIOLOGICAL THERAPIES ON WORK IMPAIRMENT AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE PATIENTS
REAL-WORLD IMPACT OF BIOLOGICAL THERAPIES ON WORK IMPAIRMENT AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE PATIENTS

Tessa E.H. Römkens  et al.

THERAPEUTIC DRUG MONITORING OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS - TUMMY TRIAL
THERAPEUTIC DRUG MONITORING OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS - TUMMY TRIAL

Tessa E.H. Römkens  et al.

DE-ESCALATION OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOWING PRIOR ESCALATION
DE-ESCALATION OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOWING PRIOR ESCALATION

Tessa E.H. Römkens  et al.

OPTIMAL TIMING OF CHOLECYSTECTOMY AFTER NECROTISING BILIARY PANCREATITIS
OPTIMAL TIMING OF CHOLECYSTECTOMY AFTER NECROTISING BILIARY PANCREATITIS

Tessa E.H. Römkens  et al.

COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL
COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL

Tessa E.H. Römkens  et al.

A RANDOMIZED TRIAL OF FLUID HYDRATION TO PREVENT POST-ERCP PANCREATITIS (FLUYT)
A RANDOMIZED TRIAL OF FLUID HYDRATION TO PREVENT POST-ERCP PANCREATITIS (FLUYT)

Tessa E.H. Römkens  et al.

SUPERIOR EFFECTIVENESS OF TOFACITINIB COMPARED TO VEDOLIZUMAB IN ANTI-TNF EXPERIENCED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE DUTCH REGISTRY STUDY
SUPERIOR EFFECTIVENESS OF TOFACITINIB COMPARED TO VEDOLIZUMAB IN ANTI-TNF EXPERIENCED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE DUTCH REGISTRY STUDY

Tessa E.H. Römkens  et al.

COLONIZATION OF THE GASTROINTESTINAL MICROBIOTA WITH ENTEROCOCCUS AND STAPHYLOCOCCUS PREDICTS INFECTION IN PATIENTS WITH NECROTIZING PANCREATITIS (POEMA): PROSPECTIVE MULTICENTER STUDY
COLONIZATION OF THE GASTROINTESTINAL MICROBIOTA WITH ENTEROCOCCUS AND STAPHYLOCOCCUS PREDICTS INFECTION IN PATIENTS WITH NECROTIZING PANCREATITIS (POEMA): PROSPECTIVE MULTICENTER STUDY

Tessa E.H. Römkens  et al.

LONG-TERM OUTCOME OF THE POINTER RANDOMIZED TRIAL ON IMMEDIATE VERSUS POSTPONED INTERVENTION FOR INFECTED NECROTIZING PANCREATITIS
LONG-TERM OUTCOME OF THE POINTER RANDOMIZED TRIAL ON IMMEDIATE VERSUS POSTPONED INTERVENTION FOR INFECTED NECROTIZING PANCREATITIS

Tessa E.H. Römkens  et al.

LONG-TERM FOLLOW-UP OUTCOMES OF AN ENDOSCOPIC VERSUS SURGICAL STEP-UP APPROACH FOR INFECTED NECROTIZING PANCREATITIS (EXTENSION)
LONG-TERM FOLLOW-UP OUTCOMES OF AN ENDOSCOPIC VERSUS SURGICAL STEP-UP APPROACH FOR INFECTED NECROTIZING PANCREATITIS (EXTENSION)

Tessa E.H. Römkens  et al.

Item 1 - 12 / 12
1